Thusday's Bull: Nifty Pharma soars 2% despite fragile markets; Cipla, Cadila, Sun Pharma drive the index

Biocon was the top underperformer of the day tumbling by 1.13% at Rs402.35 per piece dragging the index.

Apr 15, 2021 11:04 IST India Infoline News Service

Amid global cues, Nifty Pharma plays safe defensive role at the juncture of fragile markets where there is the race between pandemic and vaccination. The massive restriction of economic activity in state of Maharashtra has its impact on stock markets as well. All the sectoral indices of Nifty is trading on the red except pharma and metal.

At around 11.35 AM, Nifty Pharma performs at 13,044.55 up by 237.05 points or 1.85%. The index has touched an intraday high of 13,054.50 and intraday low of 12,798.60 during early trading session.

In the last 24 hours, the Union health ministry data stated that the country reports 2,00,739 new Covid-19 cases with 93,528 discharges and 1,038 deaths. Also, more than 1.28 cr doses administered during Tika Utsav in India.

On the index window, Cipla was the top bull soaring by 4.42% and trading at Rs924.35 per piece.

Cadila Healthcare lifts the index climbing by 3% at Rs504.40 per piece.

Divi's Laboratories soared by 2.3%, while Sun Pharmaceuticals advanced by 2.06%.

Dr Reddy's (up 1.83%), Torrent Pharma (up 1.17%), Lupin (up 0.68%) also traded higher on Thursday.

However, Aurobindo Pharma (-0.05%), Alkem Laboratories (-0.79%) were trading on a bearish note.


Biocon was the top underperformer of the day tumbling by 1.13% at Rs402.35 per piece dragging the index.

Related Story

Open Free Demat Account (Rs699)